Super Micro announces 10 for 1 stock split

Super Micro announces 10 for 1 stock split


Sopa Images | Lightrocket | Getty Images

Server company Super Micro Computer on Tuesday announced a 10-for-1 stock split and issued upbeat guidance for the first quarter.

Here’s how the company did vs. LSEG estimates for the quarter that ended in June:

  • Earnings: $6.25 adjusted vs. $8.07 expected
  • Revenue: $5.31 billion vs. $5.30 billion expected

Shares in the company, which competes with companies like Dell and Hewlett Packard Enterprise, have surged over recent years as investors bet it will be an essential vendor of servers for Nvidia, whose graphics cards are powering the artificial intelligence boom.

Stock splits do nothing to change the financial fundamentals of a company but they so make each share cheaper, which can have a positive psychological effect on retail investors.

Shares of Super Micro, which joined the S&P 500 in March, surged 246% in 2023 and are up 117% year-to-date.

Super Micro shares slid as much as 4% in extended trading. The stock closed Tuesday at $618.94.

Super Micro said it expects first-quarter revenues between $6 billion and $7 billion, beating Wall Street’s estimate of $5.46 billion. It expects EPS of $5.59 to $8.27, or a $7.48 midpoint, compared to the consensus estimates of $7.58.

This is breaking news. Please refresh for updates.



Source

Investors are misreading news about the Iran war, analysts say as markets whipsaw
World

Investors are misreading news about the Iran war, analysts say as markets whipsaw

An Iranian flag flutters as a woman walks past damaged buildings amid a 10-day ceasefire between Lebanon and Israel, in the southern suburbs of Beirut, Lebanon, April 20, 2026. Marko Djurica | Reuters “Complacent” investors risk getting wrong-footed as they continue to misread developments in the Iran war, analysts said after markets reacted to the […]

Read More
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to  billion
World

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, […]

Read More
USA Rare Earth to buy Brazil’s Serra Verde for .8 billion to build supply outside Asia
World

USA Rare Earth to buy Brazil’s Serra Verde for $2.8 billion to build supply outside Asia

USA Rare Earth has announced plans to buy Brazilian rare earths miner Serra Verde in a deal worth $2.8 billion in cash and shares, as it seeks to challenge China’s dominance of the supply chain. The Oklahoma-headquartered company said it will pay $300 million in cash and $126.9 million in its own newly issued stock […]

Read More